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The present review describes brain imaging technologies that can be used to assess the effects of nutritional interventions in human sub-
jects. Specifically, we summarise the biological relevance of their outcome measures, practical use and feasibility, and recommended use in
short- and long-term nutritional studies. The brain imaging technologies described consist of MRI, including diffusion tensor imaging, mag-
netic resonance spectroscopy and functional MRI, as well as electroencephalography/magnetoencephalography, near-IR spectroscopy,
positron emission tomography and single-photon emission computerised tomography. In nutritional interventions and across the lifespan,
brain imaging can detect macro- and microstructural, functional, electrophysiological and metabolic changes linked to broader functional
outcomes, such as cognition. Imaging markers can be considered as specific for one or several brain processes and as surrogate
instrumental endpoints that may provide sensitive measures of short- and long-term effects. For the majority of imaging measures, little
information is available regarding their correlation with functional endpoints in healthy subjects; therefore, imaging markers generally
cannot replace clinical endpoints that reflect the overall capacity of the brain to behaviourally respond to specific situations and stimuli.
The principal added value of brain imaging measures for human nutritional intervention studies is their ability to provide unique in vivo infor-
mation on the working mechanism of an intervention in hypothesis-driven research. Selection of brain imaging techniques and target markers
within a given technique should mainly depend on the hypothesis regarding the mechanism of action of the intervention, level (structural,
metabolic or functional) and anticipated timescale of the intervention’s effects, target population, availability and costs of the techniques.
The brain is the most complex organ in the human body.
It contains approximately 100 billion neurons, with each
being connected by synapses to several thousands of other
neurons. The brain controls physiological functions including,
but not limited to, the sleep/wake cycle, arousal/attention,
perception, mood, motivation, emotion, appetite/satiety,
reward, learning/memory, speech, planning/executive pro-
cesses and voluntary movements. The brain is a metabolically
highly active organ that utilises a relatively large proportion
of total nutrient and energy intake throughout the lifespan.
Furthermore, the development and repair of neural tissue
depends on the proper intake of essential nutrients, minerals
and vitamins. Therefore, what we eat, or refrain from eating,
may have an important impact on our cognitive ability and
mental performance. There are two key areas in which diet
plays an important role: supporting motor and cognitive
neurodevelopment in children and preventing neurodegen-
eration and cognitive decline during ageing.
Neuronal and behavioural responses to nutrients are com-
plex and their relationships to each other are often unclear.
Nevertheless, there are several well-described routes by
which diet may affect neurochemistry and brain function.
Food and nutrient intake can modulate the availability of
precursors or act as enzyme cofactors required for the syn-
thesis and function of neurotransmitters, neurotrophic factors
and psychoactive hormones. Dietary precursors participate
in the formation and composition of neural membranes and
synapses. Nutrients also affect cerebral blood flow (CBF),
with a direct influence on energy and nutrient availability in
the brain(1). Some of the nutritional effects on brain function
(e.g. changes related to cell signalling and energy supply)
may be short lasting. For example, acute tryptophan depletion
in women vulnerable to depressive symptoms has been
shown to provoke a short-term relapse of clinically significant
depressive symptoms(2). On the other hand, supplementation
of nutrients might have long-term effects on brain structure
and function. For example, nutrient enrichment in preterm
infants can affect neurodevelopmental outcomes and brain
structure years, and even decades, after a short-term inter-
vention(3). During the last few decades, the body of evidence
from both observational and intervention human studies
investigating the modulation of brain function by nutrients
has grown dramatically. We now have a solid basis for
translation into hypothesis-driven intervention studies and,
ultimately, into evidence-based practices.
The magnitude of the economic and societal burden related
to brain dysfunction is becoming increasingly evident. A recent
study by the European College of Neuropsychopharmacology
has indicated that 38·2 % of the European Union population,
or 168 million people, suffer from a mental disorder(4). This
was estimated to cost e798 billion in 2010(5). The potential
of nutrition to reduce the burden of impaired brain function
has been illustrated by many studies reporting links between
either poor nutrient intake or nutrient enrichment and
brain function across the lifespan, from (pre)term infants to
the elderly, and in various neurodevelopmental, neurological
and psychiatric conditions(1,6–10).
Despite great progress in the fields of neuroscience,
neuropsychology and nutritional science in terms of under-
standing the relationships between brain function and
nutrition, research assessing these long-term relationships, as
well as human data regarding mechanisms of action, is
hindered by practical feasibility or methodological constraints.
In 2009, the Nutrition and Mental Performance Task Force
of the European Branch of the International Life Sciences
Institute (ILSI Europe) convened a workshop to evaluate the
methodological challenges and opportunities related to study-
ing the long-term effects of nutrition(11). One recommendation
from the workshop was to include brain imaging biomarkers
as secondary endpoints in future intervention studies to
produce study outcomes that supplement clinical or cognitive
measures. Brain imaging biomarkers might improve our
understanding of mechanisms of action and may potentially
provide more sensitive measures that predict long-term effects
earlier, thereby shortening the required trial duration(12).
The aim of the present review was to provide a com-
prehensive overview of brain imaging techniques and the
existing knowledge regarding the quality of imaging markers
commonly used to assess brain structure and functions in
human subjects. Specifically, we describe MRI and its multi-
modal assessment capacity, electroencephalography (EEG)/
magnetoencephalography (MEG), near-IR spectroscopy (NIRS),
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positron emission tomography (PET) and single-photon
emission computerised tomography (SPECT) from the per-
spective of how they could have a place in nutritional
intervention studies (Table 1). We have included a description
of the aforementioned brain imaging techniques, the bio-
logical relevance of their measures, their practical feasibility,
their sensitivity to age and in specific populations, and their
recommended use in nutritional intervention studies. Such
descriptions are expected to contribute to the identification
of an appropriate set of relevant imaging measures with
two main features. On the one hand, these techniques may
allow the measurement of neurostructural, neurophysiological
and neurochemical changes occurring over the lifespan and
after nutritional interventions. On the other hand, they may
elucidate the specific biological processes implicated in the
changes in brain function during development and ageing
and the means by which a nutritional intervention can modu-
late these changes. Of particular note, we have focused on the
general population, especially those age groups that may be
particularly sensitive to factors influential in periods of rapid
brain development or to deteriorating brain function (e.g.
infants and elderly).
MRI: brain structural, metabolic and functional
assessments for nutritional research
MRI techniques as a multimodal approach
The advent of non-invasive MRI was a breakthrough to assess
the human brain in vivo, greatly expanding the possibilities of
investigating brain structure and function. It was originally
developed as a medical imaging tool to provide detailed
scans of the structures of internal organs, using magnetic
fields and radiofrequency pulses. The MRI scanner uses a
very powerful magnetic field to align atoms in the body.
Radiofrequency pulses are then applied to disturb this align-
ment; as the nuclei return to alignment, they rotate and pro-
duce an electrical field that the scanner detects and uses to
produce images. In the case of the brain, MRI scans provide
detailed pictures of grey and white matter, vessels, cerebrosp-
inal fluid and bone. Clinically, neuroradiologists usually inter-
pret scans by visual inspection; however, in order to reveal
more subtle features, other techniques that depend on post-
acquisition processing of the scans have been developed.
The combination of MRI as a multimodal tool with post-
acquisition processing techniques provides a powerful
technology for the study of the effects of nutrition on brain
development and ageing. Within the broad divisions of
macro- and microstructural, metabolic and functional imaging,
a variety of techniques have emerged from magnetic reson-
ance (MR), leading to a multimodal assessment of the brain.
For the examination of overall brain structure, a three-
dimensional anatomical dataset of T1- and T2-weighted
images, basic scans that provide a good contrast between
grey matter and white matter, is collected, allowing recon-
struction of the brain in three planes. Diffusion-weighted
imaging and diffusion tensor imaging (DTI) datasets provide
measures of water diffusion properties within the tissue and
determine the microstructural characteristics of white and
grey matter. In addition, magnetic resonance spectroscopy
(MRS) based on proton (1H-MRS) and 31P (31P-MRS) magnetic
properties measures the levels of different metabolites in body
tissues, and functional MRI (fMRI) can be used to reveal brain
structures and processes associated with perception, thought
and action in response to sensory stimuli. The neural activity
of the brain is closely linked to changes in blood flow and
blood oxygenation in the brain (known as haemodynamics).
Additional details on these measurements are given in Table 1.
Costs of MRI may vary regionally but are relatively high, not
only due to the scanning time (depending on the number of
MR sequences needed) and the cost of the equipment, but
also in terms of image post-processing and analysis.
MRI acquisition, post-processing and MRI-derived
measures
In human subjects, MRI scans are most commonly obtained
using a scanner with a magnetic field strength of 1·5 or 3 T.
All studies begin with the acquisition of scans using an imaging
protocol designed to provide the information best suited to the
chosen method of analysis. In order to compare different
groups of a clinical/research study, the image signal and its
properties need further post-processing operations to gather
useful, reliable and comparable data. Different types of data
are provided by the different methods. Some of the most
widely used protocols and their respective post-processing
considerations are described in the following sections.
Structural MRI. Morphometry and volumetrics refer to the
measurement of physical form characteristics such as volumes
of brain structures or thickness of cortices. Originally, these
could only be measured manually by drawing about the
perimeter of a structure on a series of T1–T2 conventional
scans and then calculating the volume. Because it was time
consuming and prone to error in some instances, its use was
also restricted to structures that were clearly delineated (e.g.
the hippocampus) rather than to those with less clear bound-
aries (e.g. some frontal lobe areas). Semi-automated and fully
automated methods that label the neuroanatomical structures
on the basis of probability information obtained from a train-
ing set of images that have been manually labelled have now
become available(13). The volumes of these structures (Fig. 2)
are calculated and can then be used in statistical analyses. Cor-
tical thickness can be estimated by means of an automated
surface reconstruction scheme(14–20), and scans from different
time points or individuals can be compared at each vertex
across the entire cortical mantle and may be related to other
variables of interest. These techniques have been validated
via histological(21) and manual measurements(22). The cortical
surface can also be parcellated into a number of different
regions of interest, for which information on surface area,
thickness and volume can be estimated(23).
Voxel-based morphometry (VBM)(24) was designed to inves-
tigate local differences in the distribution of grey and white
matter in the brain. The scans are segmented into separate
grey and white matter images and entered into the VBM anal-
ysis; for analytical purposes, the brain is divided into small
S. V. Sizonenko et al.S4
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Table 1. Summary of the key features of imaging measurements
Method Measures
Structure, function
and metabolism
Biological and
clinical relevance Acute/chronic Temporal/spatial Age Availability Cost Remarks
MRI, fMRI and MRS
Structural 3D MRI Grey/white matter density
and volumes and
cortical thickness and
folding; proton charac-
teristics, e.g. density
and relaxation times
Gross neural
macrostructure
Overall brain growth
or atrophy; brain
maturation
Acute/chronic.
Excellent for
studying the long-
term effects of
early intervention
Good spatial
resolution
0–6 months;
$4 years*
High Medium Non-invasive; becoming
more available as
scanners proliferate;
variety of analysis
tools available; high
reliability
DTI Diffusion measures
(ADC and FA)
Neural microstruc-
ture and tissue
properties
Degree of diffusivity and
alteration of micro-
structure in correlation
with development,
ageing and interven-
tion
Acute/chronic.
Excellent for
studying the long-
term effects of
early intervention
Good spatial
resolution
0–6 months;
$4 years*
High Medium As given above
fMRI Neuronal function (VO2) Neural activity in
resting state or
in response to
stimuli
Neuronal activation Acute/chronic Low temporal resol-
ution and good
spatial resolution
0–6 months;
$4 years*
Average Medium As given above
H-MRS Metabolic profile: cre-
atine; lactate; N-acetyl
aspartate; myoinositol;
choline; glutamate/
glutamine
Energy metab-
olism; neural
integrity; mem-
brane com-
ponents; neuro-
transmission
Currently exploratory:
changes in brain
metabolism during
development, ageing
and intervention
Probably excellent
for studying the
acute effects of
intervention. Not
clear for long-
term changes
Good temporal and
spatial resolution
0–6 months;
$4 years*
Average Medium As given above
P-MRS Phosphomonoesters;
phosphodiesters;
phosphocreatine; ATP;
energy phosphates
Neural membrane
formation and
breakdown and
cell energy
metabolism
Currently exploratory:
during development,
ageing and disease,
metabolite changes
measured in 31P-MRS
have been monitored
and normative curves
for normal develop-
ment have been
established
Probably excellent
for studying the
acute effects of
intervention. Not
clear for long-
term changes
Good temporal and
spatial resolution
0–6 months;
$4 years*
Low Medium As given above
EEG/MEG Resting-state brain
activity/ERP/ERF
Electrical curren-
ts/magnetic
fields mainly
generated by
synchronised
activity of corti-
cal neurons
Changes in brain activity
during rest, sensory
stimuli and cognitive
tasks in healthy and
diseased states as
well as during devel-
opment and ageing
Acute/chronic Very good temporal
resolution and poor
spatial resolution
(standard EEG);
moderate spatial
resolution (high-
resolution EEG)
and high spatial
resolution (MEG)
All ages High Low/
medium
Non-invasive, inexpen-
sive, high temporal
resolution, low-to-
moderate spatial
resolution, highly
translational, neural
correlates of resting
state and cognitive
function
NIRS Oxygenated and deoxy-
genated Hb in the
upper layers of the
cortex
Neural activity
and/or simple
cerebral blood
flow and oxy-
genation
Varies with age and
within neurodevelop-
mental and neuro-
pathological groups
Early systems most
suited to acute
studies, but
newer quantitative
systems are well
suited to acute or
chronic designs
Poor spatial resolution
and high temporal
resolution
All ages Low Low NIRS has shown utility
in some relatively
simple nutritional
intervention studies,
and the newer
quantitative systems,
combined with the
employment of
multiple channels, will
make this a practical,
low-cost technique
in future studies
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cubic elements called voxels. Most commonly, groups of scans
are compared on a voxel-by-voxel basis to determine where
significant differences in the concentration, volume and/or
density of grey or white matter occur between groups.
Voxel-by-voxel correlations with other variables (e.g. beha-
vioural) can also be determined. These analyses produce
statistical parameter maps showing where differences between
groups (if any) and significant relationships with other variables
occur.
Sulcation and gyrification index analysis can be used to
assess cortical folding in vivo and to define a sulcation
index during development or disease. The analysis uses the
white matter and cortical grey matter contrast intensity inter-
face(25). A dramatic increase in the sulcation index, corre-
sponding to brain maturation from an unfolded state to its
gyrificated mature state near term, has been demonstrated
between 26 and 36 weeks of gestation(25).
Diffusion-weighted imaging/DTI captures microstructural
characteristics not apparent in standard anatomical images
by utilising the restricted water diffusion in biological brain tis-
sues. Depending on microscopic tissue characteristics (e.g.
properties of cell membranes, tissue orientation and myelina-
tion), water diffusion will differ by degree and direction. In
DTI, a first pulse introduced to the magnetic field determines
the initial position of the protons carried by water, while a
second pulse detects how far they have moved in space and
in which specific direction(26). In this way, we obtain a
metric of water diffusion, sensitive to structural characteristics.
The number of directions of diffusion measured varies from
a minimum of 6 to .100.
Several DTI metrics can be applied. Fractional anisotropy
(FA) is an intra-voxel index of the degree of diffusion
anisotropy (i.e. directionality of diffusion). Several features
contribute to FA, including myelin and axonal integrity(27,28),
and also complex structural features such as the degree
of fibre crossing(29). The constituents of FA are diffusion
measured parallel/axial to, and perpendicular/radial to, the
principal diffusion direction. In white matter, axial diffusion
usually means diffusion along the length of the axon. Any
neurobiological inference based on DTI measures must be
made with caution, since multiple features influence the
metrics(30). However, some hypotheses may be made,
depending on the group studied. For instance, to the extent
that a nutrient facilitates myelin or axon membrane integrity,
one might expect higher FA and lower diffusion measured
perpendicular/radial in selected regions in a nutrient-
facilitated group. Another commonly used metric is the
mean diffusivity, reflecting the degree of diffusivity in any
direction. This is an illustration of the tissue microstructure
and water content.
There are various ways of evaluating metrics and analysing
DTI data. One can delineate tracts of interest or define regions
of interest manually, or use automated tools, to conduct
voxel-wise statistical analyses of FA, diffusion measured
perpendicular/radial, diffusion measured parallel/axial or
mean diffusivity data. This can, for example, be done within
a white matter skeleton containing only voxels common toTa
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groups of participants by using tract-based spatial statistics(31),
part of the FMRIB Software Library(32) (see Fig. 3 for an example).
MRS proton spectroscopy and phosphorus spectroscopy.
The MRS signal produces a spectrum of resonances that corre-
spond to different molecular arrangements of the 1H-proton
and 31P being excited. 1H-MRS and 31P-MRS measure different
metabolites that are respectively linked to specific brain com-
position and metabolism (Table 1). Because 31P is in lower
concentrations in the body than 1H, it has a lower signal:noise
ratio and therefore a higher magnetic field is required to
achieve a better spectral resolution (Fig. 1; Tables 2 and 3).
Furthermore, these techniques do require specific hardware.
It must be noted that with an increasing magnetic field,
spectral resolution is increased, allowing more precise
measurements of the targeted metabolites. Both can be used
to follow normal metabolic development and to detect
disorder-linked metabolic change. 1H-MRS allows neural
measurements of absolute metabolite concentrations during
development, such as choline, creatine, glutamine/glutamate,
lactate, myoinositol, macromolecular contributions, N-acetyl-
aspartate (NAA) and taurine(33–35). As gestational age incre-
ases, significant increases in NAA, glutamate and glutamine,
creatine, taurine levels, with decreases in lactate, myoinositol
and phosphoethanolamine levels, have been shown(33,34,36).
Regional differences are also present: subcortical areas such
as the thalamus showed early high levels of total creatine
and NAA, but, by contrast, periventricular white matter
showed very little NAA and lactate resonance(33,34,36). In the
adult and ageing normal brain, MRS has also been able to
characterise MRS-measured metabolite changes with age and
region. Mainly, NAA, NAA:choline and NAA:creatine ratios
are decreased in the hippocampus as well as in the semioval,
temporal and frontal regions in ageing brains(37,38). Further-
more, altered neuronal and glial mitochondrial functions are
also present in ageing brains and could be in part linked to
brain function decline(39,40). Glutamate, an important neuro-
transmitter, is reduced in the grey matter of the ageing
brain(41,42). White matter tracts also show altered NAA:choline
and NAA:creatine ratios for the corpus callosum and sple-
nium(43,44). These changes in grey and white matter metab-
olism appear to be linked to the reduction of cognition seen
in normal ageing(44–46).
31P-MRS specifically evaluates energy and phospholipid
metabolism by using phosphocreatine, ATP, inorganic phos-
phate, phosphocholine and phosphoethanolamine measure-
ments(35). In addition, the chemical shift of inorganic
phosphate is dependent on intracellular pH, allowing
tissue pH calculation. During development, ageing and dis-
ease metabolite changes measured in 31P-MRS have been
monitored and normative curves for normal development
have been established(35,47–51).
Functional MRI. Active neurons consume energy for the
duration of ongoing processing, resulting in a higher oxygen
need and a higher blood flow. This haemodynamic response
rises to a peak over 4–5 s, after which it normalises, leading
to local changes in the relative concentration of oxygenated
Hb (oxy-Hb) and deoxygenated Hb (deoxy-Hb) and changes
in local cerebral blood volume in addition to this change in
local CBF(52–54). fMRI measures these changes in blood
oxygen concentration by recording changes in blood oxygen
level-dependent (BOLD) signal. Oxy-Hb is a diamagnetic mol-
ecule and becomes paramagnetic when deoxygenated. The
(a1)
(a2)
(a3)
(a4)
4 3 2 1 0 20 15 10 5 0 –5 –10 –15 –20 –25
ppm ppm
(b1)
(b2)
(b3)
(b4)
PDE
Cho
(a) (b)
Cr
NAA
PME
PCr ATP
lac
pi
Fig. 1. 1H-MRS and 31P-MRS at 1·5 T. (a) Normal typical spectrum of proton spectroscopy of grey matter and changes during brain development. (a1) Normal
preterm infant born at 29 weeks of gestation (scan at 35 weeks), (a2) normal-term newborn, (a3) normal infant of 6 months and (a4) normal adult. (b) Normal typi-
cal spectrum of 31P spectroscopy of grey matter and changes during brain development. (b1) Normal preterm infant born at 29 weeks of gestation (scan at
35 weeks), (b2) normal-term newborn, (b3) normal infant of 6 months and (b4) normal adult. Cho, choline; Cr, creatine; NAA, N-acetylaspartate; Lac, lactate;
PME, phosphomonoesters; Pi, inorganic phosphates; PCr, phosphocreatine; PDE, phosphodiesters; NTP, nucleotide triphosphate. Reproduced from Robertson &
Cox(254).
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MR signal of blood is therefore slightly different depending on
the level of oxygenation in the local capillaries. These differ-
ential signals can be detected using an appropriate MR pulse
sequence (i.e. the BOLD signal mentioned previously).
Higher BOLD signal intensities arise from decreases in the
concentration of deoxy-Hb. These changes can be either posi-
tive or negative depending on the relative changes in both
CBF and VO2. Increases in CBF that exceed changes in VO2
will lead to an increased BOLD signal. In contrast, decreases
in CBF that outstrip changes in VO2 will cause decreased
BOLD signal intensity(55).
Eligibility for an MRI examination
MRI is a non-invasive technique involving the use of
magnetic fields and radiofrequency pulses and, hence, no
ionising radiation. No clinical side effects have been noted
after more than two decades of relatively broad use. As well
as making its use in research viable, this also means that scan-
ning can be repeated several times with the same persons,
which is important in studying the effects of nutrition on
development, ageing or the prevention of disease-related
changes.
Although it can be widely used in the population, there
are some contraindications to scanning. People with ferro-
magnetic implants are often unsuitable for scanning as the
images would be distorted, and pacemakers will be disturbed
by the magnetic field, making scanning not an option for
some groups. Dental braces in children may also result in
distorted images. Furthermore, persons with claustrophobia
or fear of narrow spaces often do not tolerate the typically
rather narrow space in the scanner. The ability of a person
to avoid moving in the scanner is critical for any type of MR
image to be obtained.
An important consideration when using imaging in infants
and children is the age at scan acquisition. Until a few
months after birth, MRI scanning is fairly accessible and can
be performed under natural sleep after feeding. In naturally
sleeping infants, fMRI can be performed and resting-state
activity, as well as response to light, auditive and smell stimu-
lation, can be measured. For older children, the sequences
used in structural imaging and DTI can be made quite short,
often less than 10 min. However, this may still be a long
Fig. 2. Whole-brain segmentation of a T1-weighted scan as implemented in FreeSurfer (a brain imaging software package)(24). The segmentation is shown in (a)
coronal, (b) horizontal and (c) sagittal views. Each image element (voxel) of the brain volume is labelled as belonging to different structures. For instance, the hip-
pocampus is labelled in yellow.
Fig. 3. From diffusion tensor imaging, measures of fractional anisotropy (FA) can be derived. Areas of higher diffusion directionality, or FA, are shown in a lighter
colour (a) coronally and (b) horizontally. The white matter skeleton created by tract-based spatial statistics as implemented in FSL(41) contains only tract voxels
common to all participants in a study and is shown here in green imposed on the FA volume. To the right (c), the direction of diffusion in different parts of the
brain is shown colour coded. Red colour denotes diffusion along the medial– lateral axis (such as in the corpus callosum connecting the hemispheres). Green
colour denotes diffusion along the posterior–anterior axis, while blue colour denotes diffusion along the inferior–superior axis.
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time for young children to keep still and the option of seda-
tion is only warranted in the case of clinical scans. The success
rate may increase in school-aged children. Some centres use
pre-scan training in a mocked-up scanner to reduce the age
limit of viability. To enhance cooperation, audio books/
music can be played at the time of scan, and if the equipment
allows, cartoons may be projected or viewed in special gog-
gles. For fMRI studies, stimuli–response paradigms have to
be adapted to the age of the children and their ability to
understand the task. Using MRI in the early years of childhood
is difficult but important due to the fact that great brain
development is ongoing during childhood and MRI could
thus provide crucial information on the effects of nutrition
during brain development. The plasticity of the brain during
this period indicates that it may be a likely time for nutrition
to influence structural changes. Studies that have followed
up subjects after early dietary intervention, however, have
shown that the effects tend to persist over time(3,56); thus,
brain scans obtained later in childhood may still be
informative.
From a broader point of view, due to reasons des-
cribed above, neuroimaging studies should include uniform
samples with regard to the age or, if subjects who vary
widely in age are included, age at the scan should
be used as a covariate in analyses. This is particularly true
in childhood, in which the development occurs over a rela-
tively short time span.
Use of MRI in nutritional studies
Past nutritional studies that have used MRI techniques. If we
discount studies in clinical populations, the number of nutri-
tional intervention studies using imaging measures is minimal.
This is not surprising since it has been unusual in the past for
research centres to collect both the nutritional and MRI data
necessary to conduct these studies, but a few reports have
started to appear. Nutritional studies tend to concentrate on
the two extremes of the age spectrum, infancy and old age,
periods in life with relatively large changes in brain mor-
phology and functionality. There is, however, a difference in
emphasis between the two. While studies in children have
investigated whether different nutrition regimens can enhance
brain development, studies in adults have tended to focus on
whether diet and nutrients may act to protect the brain from
age-associated atrophy or disease. It is important to keep in
mind that structural changes may not correspond directly to
changes in function and that such structural changes may
bias the results. Grey matter atrophy and sulcal expansion in
older adults may be responsible for a great anatomical varia-
bility between the brains of younger and older adults and
Table 2. Absolute concentrations of brain metabolites in individuals of different age groups in mmol/kg brain tissue and significance tests for
differences found*
(Mean values with their standard errors)
ROI (n)
GA (weeks)
pn age
(weeks) NAA Cr Cho ml
Groups Mean SEM Mean SEM Mean SEM Mean SEM Mean SEM Mean SEM
,42 GA 11 38·7 0·7 3·9 1·6 4·82a 0·54 6·33 0·32 2·41 0·11 10·0 1·1
42–60 GA 8 50·2 1·8 9·3 1·9 7·03 0·41 7·28 0·28 2·23 0·06 8·52 0·92
,2 pn 6 40·0 1·0 0·8 0·2 5·52 0·64 6·74 0·43 2·53 0·12 12·4 1·4
2–10 pn 7 41·9 1·5 3·8 0·9 5·89 0·21 6·56 0·44 2·16 0·09 7·69 0·62
Adult 10 1440 68 8·89 0·17 7·49 0·12 1·32 0·07 6·56 0·43
P
,42 GA v. adult ,0·0001 ,0·0001 ,0·0001 0·001
, 42 GA v. 42–60 GA 0·0007 0·02 0·07 0·10
42–60 GA v. adult ,0·0001 0·16 ,0·0001 0·0003
42–60 2 pn v. adult ,0·0001 0·005 ,0·0001 ,0·0001
2 pn v. 2–10 pn 0·7 0·8 0·02 0·004
2–10 GA v. adult ,0·0001 0·001 ,0·0001 0·007
ROI, region of interest; GA, gestational age; pn, postnatal age; NAA, N-acetylaspartate; Cr, creatine; Cho, choline.
* Reproduced from Ross & Bluml(35).
Table 3. Concentrations of 31P metabolites in healthy brains of human neonates, infants and adults†
(Mean values and standard deviations)
Concentration (mmol/l ¼ mmol/dm3)
PME Pi PDE PCr ATP 31P total
n Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD
Neonates 16 4·5** 0·7 0·6*** 0·1 3·2*** 0·8 1·4*** 0·2 1·6*** 0·2 14·9*** 2·3
Infants 17 3·6 0·9 0·6 0·1 4·2 0·7 1·7 0·3 1·8 0·3 16·1 2·5
Adults 28 3·5** 0·6 1·0*** 0·2 11·7*** 2·2 3·4*** 0·5 2·9*** 0·4 29·3*** 3·1
PME, phosphomonoesters; Pi, inorganic phosphates; PDE, phosphodiesters; PCr, phosphocreatine.
Mean values are significantly different: **P,0·01, ***P,0·001.
† Reproduced from Buchli et al.(255).
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within a single random sample of older individuals(57,58).
Therefore, it is important to define structure–function relation-
ships. Some examples of studies are presented below.
MRI studies of altered nutrition during fetal life: effects on
the brain during intrauterine growth retardation. Three-
dimensional MRI has been used to evaluate the effects of
intrauterine growth retardation (IUGR) on brain development.
IUGR can be considered as inadequate nutritional supply
during pregnancy. Preterm IUGR infants show altered brain
development with reduced cortical grey volumes(59), hippo-
campal volumes(60) and sulcation index(61) compared with
normally grown preterm infants. These changes are correlated
with altered neurodevelopmental scores. Thus, early cortical
development seems to be modified by altered intrauterine
nutritional environment(61).
DTI has also been used to assess the effects of IUGR on the
microstructural development of the brain. Results have shown
a higher apparent diffusion coefficient value in the internal
capsule of IUGR infants at birth compared with that of non-
IUGR infants. This change persists at term, indicating reduced
maturation in this area, which represents a major white matter
fibre tract that normally myelinates between 34 and 40 weeks
of gestational age. Further results have indicated reduced rela-
tive anisotropy with a less well-developed fibre tract system at
birth in the corpus callosum, the main interhemispheric
connection system(62). VBM has verified these findings by
revealing similar regions of microstructural changes in IUGR
preterm infants when compared with control groups(63,64).
1H-MRS has shown altered metabolites in grey and white
matter in preterm infants with IUGR(64,65). In grey matter,
NAA and myoinositol levels were reduced in the compro-
mised group and energy supply alteration with increased
creatine levels could also be measured. In white matter, similar
alterations were present in infants with IUGR; in addition, an
increased level of lactate was found, indicating altered metab-
olism, possibly due to astrocyte metabolism changes.
MRI studies of nutritional effects on the brain in children.
Very few reports exist, but a study by Taki et al.(66) has illus-
trated how MRI could be used. The authors divided 290
healthy 11-year-old children into three groups, depending
on their breakfast staple (rice, bread or both), and used
VBM to look for differences in grey and white matter and
also compared intelligence quotient (IQ) measures among
the groups, incorporating covariates such as socio-economic
class and age. Differences in both overall and regional grey
and white matter volumes among the groups have been
reported as well as a significant advantage for the rice group
in the Perceptual Organisation Index Score of the IQ test.
The glycaemic index has been suggested as a possible expla-
natory mechanism.
The best evidence for nutritional effects on the brain would
be to obtain MR images as an outcome measure for children
who had taken part in an earlier randomised controlled trial
of a nutritional intervention. For instance, two studies have
reported structural and cognitive outcomes at adolescence in
a subgroup of a cohort of preterm infants (all neurologically
normal) who had taken part in a randomised feeding trial peri-
natally(67). In one study, a high-nutrient diet was associated
with larger volumes of the caudate nuclei and a higher
verbal IQ, but only in boys(68). In a later report, the percentage
of maternal breast milk in the infant diet was associated with a
greater white matter volume and a higher verbal IQ; again, the
effects were stronger in boys(69).
VBM has been used to demonstrate relationships between
regional brain volumes and IQ(70) as well as more specific
cognitive functions such as reading(71), calculation(72) and
executive function(73). Likewise, other techniques, both
whole-brain segmentation and surface reconstruction, yielding
volumetric and cortical thickness measures, have also shown
sensitivity to differences in cognitive and behavioural func-
tions. These techniques could therefore be used to explore
whether a nutritional intervention affects such outcomes.
MRI studies of nutritional effects on the brain in adults.
There are multiple mechanisms by which nutrients or
supplements may serve to protect the ageing brain(74,75),
including by lowering cerebrovascular disease, inflammation
and/or oxidation. A recent, large study of elderly subjects
has shown associations between image measures of brain
health and cognitive function, on the one hand, and plasma
biomarkers of vitamin and fatty acid status and trans-fat, on
the other hand(76).
There is much literature showing that elevated homocys-
teine levels are negatively related to cognitive function in
ageing(77–80) with good indications from MRI studies that the
cognitive effects may be mediated through brain atrophy,
hyperintensities and/or subclinical infarcts(79,81–83). Still, it
may be that elevated homocysteine levels are not a causal
mechanism for brain atrophy and cognitive deterioration,
but rather a by-product. However, this possibility has recently
been weakened by a large well-controlled intervention
study(84). The study was a randomised double-blind controlled
trial using high-dose folic acid and B vitamins in persons aged
.70 years and categorised as having mild cognitive impair-
ment. MRI scans were performed at the start and end of the
study after 2 years. The mean rate of brain atrophy per year
was significantly lower in the treatment group than in the
placebo group and the treatment response was related to
baseline homocysteine levels. The greater rate of atrophy in
the placebo group, primarily seen in the images as an enlarge-
ment of the ventricles, was associated with a lower final
cognitive test score (Mini-Mental State Examination and
Telephone Interview of Cognitive Status).
A recent study on long-chain PUFA (LC-PUFA) has shown
that among older adults, dietary intake of fish with a higher
EPA and DHA content was associated with a lower prevalence
of subclinical infarcts and white matter abnormalities on MRI
examinations(76,85,86). This finding was extended by the obser-
vation that in middle-aged adults, DHA, but not EPA or a-lino-
lenic acid, in serum, was associated with improved non-verbal
reasoning, working memory and vocabulary(86).
Choline, a precursor of acetylcholine and phosphatidyl-
choline, is important for brain metabolism and is largely
obtained from the diet. Cohen et al.(87) measured plasma
and brain choline levels with 1H-MRS after a single choline
supplement in young and aged healthy subjects. The results
showed that despite a similar choline increase in plasma in
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both groups, the brain levels of choline measured by 1H-MRS
were lower in the aged group, indicating a decrease in choline
uptake into the brain with age(87). Given the role of choline in
cholinergic neuronal function, the reduced uptake of choline
may be involved in altered brain function in the elderly and in
neurodegeneration. Similarly, in a study on healthy adults using
31P-MRS, administration of uridine appeared to increase brain
membrane precursors (phosphomonoesters: phosphocholine
and phosphoethanolamine)(88). Furthermore, studies have
shown altered membrane phospholipids and fatty acid metab-
olisms in psychiatric or epileptic diseases using 1H-MRS and31P-
MRS(89,90). It has also been reported that citicoline improves fron-
tal lobe bioenergetics and alters phospholipid membrane turn-
over. It may therefore help to mitigate cognitive declines
associated with ageing by increasing energy reserves and utilis-
ation, as well as increasing the amount of essential phospholipid
membrane components needed to synthesise and maintain cell
membranes(91). In psychotic adults, ethyl-EPA supplementation
appears to improve symptoms in relation to an increase in brain
glutathione levels and glutamate:glutamine ratio measured by
1H-MRS, which can be linked to improved antioxidative defence
through astrocyte metabolism(92).
In the last few years, fMRI has been used to investigate the
mechanisms related to the physiological or pathological
regulation of food intake, as well as the cognitive/affective
processing of food-related stimuli(93). These studies have
identified a food-related functional recruitment in both
sensory processing and emotion-related structures, including
prefrontal, orbitofrontal temporal and cingulate regions,
amygdala and insula. Nonetheless, few fMRI studies have
tried to determine the role of nutrition in brain function.
Recently, fMRI has been used to examine the effect of
nutrition in young healthy volunteers who had a breakfast
including various nutrients (i.e. food containing proteins,
lipids, vitamins and minerals as well as carbohydrates) when
compared with when they skipped breakfast or had only
sugar for breakfast(94). When participants were performing
memory and attention tasks, significantly higher brain acti-
vation was observed in the medial prefrontal areas, but only
following the nutritionally balanced breakfast.
Methodological limitations and recommendations of
relevance to intervention studies
Any effects of nutrition found by MRI studies will need to be
interpreted with care. Ideally, all of the scans for one study
should be obtained using the same scanner and the same
imaging protocol, because variations can complicate the
interpretation of results. However, this is often not feasible
in large-scale studies, and therefore standardised protocols
across sites and scanner platforms allow data to be pooled.
This can greatly increase the number of subjects and hence
possible analyses. In recognition of this, multi-site initiatives,
such as the Alzheimer’s Disease Neuroimaging Study (http://
www.adni-info.org/), have been launched in recent years,
indicating that consistent and valuable results can be obtained
across sites and platforms(95). With standardisation criteria
carefully being tested and employed, multi-site initiatives
can be highly powerful.
Findings from structural studies can be used to illustrate the
complexities of linking structure to function. It is well known
that a reduction of MRI-derived volume is often observed
along with diminished cognitive function in injury or central
nervous system (CNS) disorders, such as Alzheimer’s disease
(AD). However, while a ‘bigger is better’ view has sometimes
been supported in the study of relationships between normal
brain structures and cognitive abilities, this is not likely to
hold independently of groups studied(96). For instance, a
decrease in cortical thickness is seen with increased cognitive
function in school-aged children(97,98), yielding a negative cor-
relation of cortical thickness and cognitive performance scores,
whereas a shift in the direction of this relationship is seen during
ageing(99–101), with thinner cortices usually being accompanied
by some reduction of cognitive speed performance scores.
This probably occurs because in children, cognitive develop-
ment is enhanced by pruning or fine-tuning of synaptic connec-
tion, along with intracortical myelination, processes that would
make the cortex appear thinner in MR images. On the other
hand, during ageing, loss of synaptic spines and synapses, as
well as neuronal shrinkage and possible neuronal loss, would
decrease both cortical thickness and cognitive function. Thus,
the relationship between volumetric/cortical surface character-
istics and cognitive outcome is not constant throughout life.
Due to the high sensitivity of MRI to blood flow, it is crucial
to recognise that not all interventions leading to a change in
the BOLD signal may necessarily also lead to a perceivable
behavioural change in examined subjects(102). Nonetheless,
several studies have identified an association between blood
flow and metabolic rate, suggesting that the blood supply is
tightly regulated in space and time to provide the nutrients
for brain metabolism(103). Importantly, structure–function
relationships need to be defined to better understand
disease- or nutrition-induced changes. This can be done
using a stimulus–response paradigm and correlation with
structural changes.
Furthermore, alterations in cognitive function due to ageing
may depend on the specific task or function explored and
may vary from one brain region to another. It is known, for
example, that brain activity may be reduced in older persons
when compared with younger individuals in prefrontal
cortex(104) or medial temporal areas(105) during different
memory tasks. On the other hand, an over-recruitment of the
prefrontal cortex has often been described in older healthy sub-
jects during execution of various cognitive tasks(106). Therefore,
participant selection and screening may be fundamental in
cross-section evaluations(107). For instance, the inclusion of
relatively high-functioning elderly individuals may bias the
cross-sectional results in such a way that the cross-sectional
analyses indicate an over-recruitment of the dorsal frontal
cortex, while the longitudinal analysis reveals an age-related
activity reduction in the same frontal regions(107).
Structural and functional data transformations should be
carefully verified and, when available, population-specific
templates should be used to optimise alignment and reduce
distortions(108). However, it is important that the variability
Brain imaging and human nutrition S11
B
ri
ti
sh
Jo
u
rn
al
o
f
N
u
tr
it
io
n
https:/www.cambridge.org/core/terms. https://doi.org/10.1017/S0007114513001384
Downloaded from https:/www.cambridge.org/core. University of Basel Library, on 30 May 2017 at 22:18:55, subject to the Cambridge Core terms of use, available at
between standard templates and the study group is not too
great. For example, it is necessary to take age into account,
especially when studying infant brains, which differ a great
deal in terms of gross morphometric features from those of
older children and adults. Intracranial volume and brain size
undergo dramatic changes in the first few years of life, and
slight changes are also seen throughout the teens, but the
overall intracranial and brain volume in school-age years is
very similar to that of adults(109) and standard templates may
be used. Moreover, some classification, averaging and match-
ing techniques used employ procedures shown to be well
suited to account for varying anatomies(110).
When fMRI is used to study brain functional organisation in
individuals of different ages, it is important to take into con-
sideration that methods for fMRI data analysis are exquisitely
sensitive to blood flow. This means that cerebrovascular
changes associated with ageing could alter one or more par-
ameters of the vascular regulation(111) and hence the results.
For instance, studies that evaluated the visual cortex response
during passive stimulation have reported a decreased fMRI
signal in older adults when compared with younger individ-
uals(112,113), and this was not caused by reduced neural
activity, but rather by differences in neurovascular local prop-
erties(114). One or more valid control tasks should be used as
age-related differences in neurovascular response should influ-
ence all conditions equally. Thus, an evaluation of the size of the
within-group effect should be safer than a direct comparison of
the BOLD signal change in two age groups(115). Other possible
solution is the normalisation of the task-related signal change
by the use of breath-holding to produce global changes in
BOLD signal(116) or with a simple sensory or motor task to esti-
mate the haemodynamic response function for each individual
included in the study(117).
We discuss here some of the issues pertinent to the
consumption of supplements (84), mostly using examples on
homocysteine. While the literature linking homocysteine
levels to brain measures is impressive, some inconsistencies
and nuances of general relevance to possible nutritional inter-
vention studies should be mentioned.
Age at intervention. First, since relationships between
neuroimaging markers and nutrition indicators in adulthood
have mostly been studied in middle-aged and older individ-
uals, it is unknown whether relationships exist throughout
the adult lifespan or at which point they may occur. The
relationship between homocysteine levels and cognitive func-
tion was confined to adults aged $60 years in a large-scale
study(80). To the extent that nutrients are tested for a protective
effect, they should be studied at an age span in which negative
influences come into play (i.e. at a stage where age-associated
atrophy has accumulated or become more marked or disease-
related changes are more likely to set in).
Sex effects. There is some indication that relationships
may be stronger in men(83). This is not established enough
to justify targeting only men for nutritional interventions, but
intervention studies need to be sufficiently powered to analyse
sex effects. Since evidence for sex effects has also been found
in early intervention studies(68,69), it is probably informative to
include planned analyses by sex in all nutritional studies.
Use of multimodal imaging markers. While many studies
have found effects of nutrition indicators on the brain, the par-
ticular measures that show effects may vary and are not always
consistent across studies. For instance, while many studies on
homocysteine levels have found effects on atrophy, one study
has found no effect on atrophy, but only an effect on white
matter hyperintensities(83). Similarly, a recent study has
reported associations between total cerebral brain volume
and biomarkers of vitamin (positive) and trans-fat (negative),
while fatty acid biomarkers have been reported to be related
only to white matter hyperintensities(76). This points to the
importance of including multiple imaging measures. In
addition, in line with recent studies pointing to the unique
explanatory power of different imaging modalities relative to
each other(118), one should include several types of scans
with respect to outcome measures (e.g. T1 weighted, T2
weighted, DTI and MRS).
Regional neuroanatomical specificity of effects. To the
extent that hypotheses can be made a priori, studies should
use analysis techniques that allow for testing effects located
in specific brain systems. For instance, if fatty acids are hypoth-
esised to affect the fibre integrity or myelination of major white
matter tracts, DTI measures sensitive to this may be employed.
It has been suggested that some discrepancies in the literature
regarding the effects of B6 and B12 vitamins and folic acid, and
by implication, homocysteine levels, may stem from differences
in the sensitivity of image analysis techniques, where global
measures of brain volumes will not necessarily capture region-
ally specific effects(119). In a small study using diet diaries, evi-
dence has been found for medial volumetric effects, including
anterior cingulate and parietal areas, as well as temporal and
superior frontal effects of B6 and B12 vitamin and folic acid sup-
plement intake. Hence, studies should include analyses sensi-
tive to localised neuroanatomical effects(119).
Electroencephalography and magnetoencephalography:
measuring brain electrical and magnetic activities
Electroencephalography and magnetoencephalography
techniques and electroencephalography/
magnetoencephalography-derived measures
EEG and MEG measure brain electrical and magnetic activities
recorded from scalp electrodes and extracranial sensors, respect-
ively. Scalp EEG activity is recorded as a voltage difference; thus,
different reference derivations provide diverse voltage values at
exploring electrodes. The general procedure for the recording
of scalp EEG activity involves the positioning of an elastic cap
with cabled cup electrodes or single-cup electrodes in standar-
dised locations of the scalp. EEG procedures are especially suit-
able for multicentric studies, since EEG systems are always
present inneurological departments and theEEGdataof different
recording systems can be harmonised using calibration signals of
a defined voltage amplitude (i.e. 100mV).
MEG activity is a reference-free measure recorded by
superconducting quantum interference devices, which are
sensors able to transform very small magnetic fields into
recordable currents. The general procedure for the recording
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of extracranial MEG activity involves the demagnetisation of
the subject and positioning of his or her head under a
helmet with superconducting quantum interference devices.
As a main merit, EEG and MEG signals have the highest
temporal resolution compared with all the current brain
imaging techniques (i.e. they can measure the amplitude of
brain electromagnetic activity with a sampling ,1 ms).
From a physiological point of view, EEG and MEG signals
derive from the post-synaptic ionic currents of synchronously
active pyramidal neurons over extended cortical regions (cm)
and reflect the integrative information processing of signals
originating in the thalamus, brainstem and other cortical mod-
ules. In these extended cortical regions, both tangentially and
radially oriented sources produce most of the scalp EEG sig-
nals, whereas only tangential sources produce MEG signals.
It is noteworthy that EEG is characterised by a low spatial res-
olution (i.e. the ability to localise the cortical source of scalp
EEG activity within several centimetres), since different con-
ductivities of head tissues (brain, meninges, skull and scalp)
attenuate and blur the spatial distribution of neural currents
from brain sources to scalp electrodes. To minimise these
weakness points, EEG activity can be recorded from 48 to
128 electrodes and can be processed to obtain reference-free
and spatially deblurred EEG activity. This can enhance the
spatial resolution of EEG to a few centimetres and eliminate
the need for a reference. With respect to EEG, the spatial
resolution of MEG is higher (several millimetres in the best
experimental conditions, namely simple evoked magnetic
fields), since magnetic fields are not affected by different
conductivities of brain, skull and scalp tissues.
The high temporal resolution of EEG and MEG signals is ideal
for investigating the emerging features of brain physiology,
namely awake resting-state brain rhythms. In this condition,
the subjects are minimally affected by anxiety, fatigue and
issues related to their cognitive–motor performance (task
difficulty, meta-learning, etc.). It is also ideal for investigating
immediate brain responses to sensory, cognitive or motor
events in short-term (acute) and long-term (chronic) interven-
tion studies. Spectral analysis methods allow the estimation of
EEG and MEG dynamics in terms of the dominant frequencies,
power (or amplitude), phase and coherence of EEG rhythms.
The background spontaneous oscillatory activity of brain neur-
ons at about 10 Hz generates the dominant alpha rhythm of rest-
ing-state EEG and MEG activities(120). Oscillations in other
frequency bands, such as d (1–4 Hz), u (4–7 Hz) and g (30–
70 Hz) bands, also exhibit complex patterns of power that are
modulated by cognitive processes such as attention, perceptual
binding and working memory(121). On the other hand, EEG and
MEG techniques can be used to study the fine timing (millise-
cond scale) of event-related or evoked cortical responses to
external stimuli, mental operations or movements (Fig. 4). Func-
tional connectivity between brain areas is crucial for perceptual
and cognitive processes that are intrinsically based on the inte-
gration of information represented in several cortical and sub-
cortical areas in the human brain. Both resting-state and the
mentioned event-related EEG/MEG measures can be used as
input for the evaluation of functional connectivity of brain net-
works. Spectral coherence (linear), directed transfer function
(linear) and synchronisation likelihood (linear and nonlinear)
techniques are typically used to do so from EEG/MEG rhythms
recorded during resting-state conditions, while event-related
covariance can be used from event-related potentials (ERP)/
event-related fields(122). The choice between EEG and MEG
techniques depends on the importance of spatial resolution
for testing the working hypothesis (effects of the intervention
on specific cortical regions).
Eligibility for an electroencephalography/
magnetoencephalography examination
EEG/MEG recordings are fully non-invasive and technically
easy procedures that can be easily repeated several times in
human subjects of any age (i.e. from newborns to elderly
people) and clinical status (i.e. patients in a coma or a vege-
tative state) without ‘repetition’ effects. It has been shown
that EEG variables correlate with individual subjects’ cogni-
tive state and specific intellectual abilities (e.g. reading)
during child development, including individuals with Down
Middle finger
extension
(a) (b)
(d)(c)
–3.5 –3.0 s
Alpha ERD Beta ERD
MRP (EMGo)
ERS ERSERD ERD
–100% 100%(EMGo) +1 s
ERD MRP
Fig. 4. Analysis in the time and frequency domains of electroencephalo-
graphic (EEG) data related to a motor event (i.e. voluntary self-paced right
middle finger extensions). (a) A schematic representation of ongoing EEG
rhythms at a frequencies (about 10 Hz) before, during and after the onset of
the electromyographic (EMGo) activity associated with voluntary self-paced
middle finger extensions. It can be seen that the amplitude of alpha rhythms
is reduced during the preparation and execution of the movement, the so-
called alpha event-related desynchronisation (ERD) and is enhanced after
the EMGo, the so-called event-related synchronisation (ERS). In the same
dataset, a slow negative shift is hidden in the EEG oscillations, namely the
movement event-related potentials (MRP). The example shows that the same
EEG dataset can be analysed in the frequency domain to compute the alpha
ERD and in the time domain to produce MRP. (b) A topographic map show-
ing cortical sources of the MRP as computed by a weighted, minimum-norm
linear inverse estimation. It can be noted that the maximum source amplitude
(red hot spot) is represented in the Rolandic region of the left hemisphere
contralateral to the movement side. (c, d) Topographic maps showing cortical
sources of the ERD at a (about 10 Hz) and b (about 20 Hz) frequencies. With
respect to the MRP, alpha and beta ERD were characterised by maximum
source amplitude (red hot spots) in the Rolandic regions of both hemi-
spheres. It is concluded that quantitative EEG techniques can reveal parallel
physiological processes underlying the activation of sensorimotor cortical
regions related to voluntary movements.
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syndrome(123); overweight or underweight adults(124,125); and
patients with disorders of vigilance, consciousness and
communication(126,127); as well as elderly subjects with intact
cognitive status or cognitive decline progressing to overt
dementia(128–134). Such a correlation is typically moderate
and emerges with relatively large populations (n . 30) and
a fine clinical and neuropsychological assessment. Further-
more, sex differences in ERP topography and amplitude
have been reported in children and adults(135,136).
EEG/MEG can be used for testing the neurophysiological
effects of pharmacological, rehabilitation or nutritional inter-
ventions immediately after an acute dose administration or
after long-term programmes. EEG/MEG recordings are suit-
able for studying the group differences in between-group
and within-group designs. Both techniques can be used in
multicentric trials since the hardware of different brands can
be easily calibrated and harmonised, although the availability
of EEG is much wider than that of MEG, largely due to the
much higher costs of MEG.
Use of electroencephalography/magnetoencephalography
in nutritional studies
In the following, we highlight a selection of EEG and MEG
papers to illustrate the resting-state, evoked potential (EP)/
evoked field and ERP/event-related field markers that capture
the short-term (acute) and long-term (chronic) effects of nutri-
ents on brain activity in healthy infants, children and adults.
Specifically, with regard to acute effects, we focus on caffeine,
and for the long-term effects of food interventions on brain
function, we focus on studies that have investigated the effects
of LC-PUFA as these nutrients have been repeatedly used to
supplement milk formulas for infants and children during
the developmental time course. Practically, no MEG studies
on the effects of caffeine and LC-PUFA have been found. In
the following paragraph, we summarise the main results and
conclusions (Babiloni et al., unpublished results, 2012).
Caffeine has evident psychoactive effects at doses compar-
able to one to ten servings of tea or cola(137) as assessed with
the behavioural measures of cognitive function. A series of
EEG and ERP studies have tested the effects of caffeine on
brain activity during wakeful resting, mainly in adults and
also in children and during ageing(138–144) (see Lorist &
Tops(145) for a review). In these studies, resting-state EEG
markers have been frequently used to study the psychoactive
effects of caffeine, mostly at relatively high doses (200–
500 mg) in adults. Generally, caffeine decreases a power,
which indicates increased alertness or arousal(146) consistent
with the behavioural literature (see Ruxton(137) for a
review). Both behavioural and EEG studies struggle with the
same fundamental questions such as how to correct for habit-
ual caffeine use and body weight and to what extent caffeine
effects can be attributed to the relief of withdrawal effects.
Therefore, traditional background EEG measures may not
add significant insights into the behavioural measures of caf-
feine effects, but it could be speculated that statistical func-
tional coupling of resting-state EEG rhythms at electrode
pairs as revealed by additional mathematical techniques, such
as spectral coherence (linear), directed transfer function
(linear) and synchronisation likelihood, might provide more
informative markers about the caffeine effects(122). These vari-
ables have been successfully used to disentangle abnormal
changes of functional connectivity in the resting-state condition
in elderly subjects suffering from preclinical or earlier stages of
AD(128–132) as well as after acute administration of nicotine,
cocaine, marihuana, alcohol or medications(147–151). The
changes in functional connectivity measures in mild AD have
been the target of a recent multi-country randomised con-
trolled trial with a medical food. The studied product provides
the nutritional precursors and cofactors for the formation of
neuronal membranes, aiming to improve synapse formation
and function in AD; hence, the study included EEG measures
as secondary outcomes as markers for synaptic connec-
tivity(152). Findings included significant amelioration in peak
frequency and functional connectivity in the d band over the
24-week intervention period in the experimental group
compared with the control, suggesting preserved and even
increased synaptic function resulting from the intervention(152).
In addition to resting-state EEG, several ERP studies have inves-
tigated the effects of caffeine on the brain using simple (e.g.
rapid visual information processing and oddball) or more com-
plex (e.g. switch task) attention tasks. ERP studies have added
more detailed insights into what aspects of attention are
improved by caffeine (generally processes following simple
stimulus processing) and at which level of information proces-
sing (complex tasks seem to show more benefits).
With regard to the effects of long-term food interventions,
LC-PUFA have been the subject of many studies, particularly
those on infant development. Several studies using ERP and
resting-state EEG measures have investigated diet-related
effects of n-3 and n-6 fatty acids in mothers and infants, as
well as in healthy adults(153–164). In summary, diets with n-3
and n-6 fatty acids can influence resting-state EEG, not only
in infants and children during development but also in
adults, suggesting increased plasticity of neuronal membranes
and synaptogenesis. The large majority of ERP studies have
focused on EP, especially visual EP have been used as func-
tional markers of the maturation of the visual system of infants
fed with a LC-PUFA-supplemented formula or a control for-
mula for 12 months(165,166). In the same vein, auditory EP or
brainstem auditory EP have similarly been used as functional
markers of the auditory system(167,168). Indeed, from a neuro-
developmental perspective, visual EP and brainstem auditory
EP are the measures of choice for probing the maturation of
the visual and auditory systems during development in infants
and children before the acquisition of the verbal skills
required for behavioural tests. Compared with the control
group, preterm infants with low birth weights (,1500 g)
receiving n-3 and n-6 supplementation for 9 weeks showed
a significantly lower amplitude of ERP in response to fre-
quently presented pictures, a possible reflection of a better
short-term recognition memory of these frequent pictures(169).
In school-aged children and adults, ERP during oddball tasks
(measuring sustaining attention to a continuous stream of
stimuli and responding to pre-specified infrequent target stim-
uli) and Go–Nogo paradigms (assessing sustaining attention
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to a continuous stream of stimuli and responding to all stimuli
except to predefined infrequent target stimuli) demonstrated
some effects of n-3 and n-6 fatty acids on visual and auditory
attention and motor processes. Sparse use of resting-state EEG
markers can be explained by the large variability of these
markers during development. Finally, the literature on the
effects of n-3 and n-6 fatty acids on resting-state MEG and
event-related fields is practically non-existent.
Methodological limitations and recommendations of
relevance to intervention studies
In the previous section, we had highlighted a selection of EEG
studies in healthy subjects on the effects of caffeine as an
example of short-term psychostimulant effects (having acute
effects on brain function) as well as LC-PUFA as examples of
nutrients that have a long-term effect on brain structure and
thus on function (chronic effects). Both resting-state EEG
and EP/ERP markers have been successfully used for this pur-
pose. For caffeine, the results are in line with the behavioural
literature, confirming that caffeine improves attention. The
majority of EEG studies on caffeine have used relatively
basic attention tasks with a large perceptual component; the
lack of use of more ‘cognitive’ attention paradigms such as
the Posner attention task(170) is striking in caffeine research,
but it is in fact present in other nutritional research. There
seems to be a disconnection between advances in behavioural
measure of attention and the development of EEG/ERP tasks.
The brain imaging area could benefit from the monitoring of
developments in the behavioural area.
For n-3 and n-6 fatty acids, visual EP and brainstem auditory
EP are even considered the gold standard for the assess-
ment of the maturity of the nervous system(168,171). In this
age group, adapted and validated behavioural measures of
development exist (e.g. the Bayley scales) and are the
preferred measures of neurodevelopment, especially in pre-
mature infants.
Moreover, we think that resting-state EEG and EP/ERP
markers could be greatly enhanced using advanced high-
resolution EEG techniques rather than simple computation
of power density spectra or amplitude/latency of EP/
ERP peaks at a few scalp electrodes. Another promising
perspective is the development of EEG markers probing the
functional coupling of EEG rhythms as revealed by spectral
coherence, directed transfer function and synchronisation
likelihood(128–132,147–151). Finally, it is expected that MEG
techniques could greatly contribute to an accurate modelling
of functional topography of the cortical sources of the
recorded MEG data in the near future, thanks to the increasing
availability of MEG systems worldwide.
Near-IR spectroscopy: measuring cerebral blood flow
and haemodynamic responses
Near-IR spectroscopy techniques and near-IR
spectroscopy-derived measures
NIRS involves the introduction of two or more wavelengths
of near-IR laser or light-emitting diode light through the
intact skull with subsequent measurement of light absorption
following diffusion through the upper layers of the cortex
by optodes positioned at a set distance from the emitter.
The differential intrinsic oxygenated and deoxygenated Hb
in the surface of the cortex give measures of oxy-Hb and
deoxy-Hb and their sum (total Hb), which represent proxy
measures of blood volume or blood flow in the interrogated
neuronal tissue; therefore, NIRS serves as a marker for
neural activation. Activity and blood flow in the brain are
inextricably linked by the neurovascular coupling of local
neuronal activity to blood flow, whereby a number of signal-
ling molecules and physiological mechanisms serve to
increase the delivery of blood-borne metabolic substrates to
active tissues(172,173). When assessed by NIRS, the haemo-
dynamic response to local neural activity will be seen as an
increase in CBF, which in turn will be evident as an increase
in the concentrations of both oxy-Hb and total Hb and a cor-
responding comparative decrease in deoxy-Hb level(174). NIRS
outcomes can therefore be taken to infer local neural acti-
vation or, alternatively, can be interpreted more directly as
simple changes in blood flow/volume in the underlying corti-
cal tissue. The latter is particularly pertinent as both CBF and
the magnitude of the haemodynamic response to neural
activity decrease with normal ageing and in neurological
disease(173). A large and expanding literature has described
the use of NIRS as a tool for multiple-channel imaging of
the haemodynamic correlates of neural activation across the
lifespan in healthy cohorts. As an example, in groups of neo-
nates, children and infants, NIRS has been used to investigate
neuronal activation across diverse cortical brain regions as a
consequence of auditory, visual and olfactory stimuli(175).
In adults, NIRS has been widely adopted to investigate the
location and extent of cortical responses during diverse
motor tasks(176), haemodynamic responses to sensory stim-
uli(177) and during cognitive tasks(178). Across these areas,
NIRS has shown itself to be sensitive enough to reliably illumi-
nate age-related changes in CBF. For instance, it has been used
to demonstrate an inverse correlation between age and hae-
modynamic response in non-elderly adults during verbal
fluency tasks(179) and hypoxia(180). Similarly, it has been uti-
lised to show reduced haemodynamic responses in older
adults in comparison with younger adults during verbal flu-
ency(181) and executive function(182) tasks, as well as during
postural changes(183) and simulated driving(184).
NIRS systems vary in complexity from single or dual chan-
nels to ‘whole-head’ arrays of several dozen channels and
fall into several categories depending on the measurement
technique that they employ: ‘continuous-wave’ systems emit
light continuously at constant amplitudes, and only the ampli-
tude decay is measured; ‘time-domain’ systems emit short
bursts of photons, with the temporal distribution providing
information about tissue absorption and scattering; ‘fre-
quency-domain’ systems emit amplitude-modulated light and
record amplitude decay and phase shift(185). Within these cat-
egories, there is a plethora of variants, and a number of new
techniques are in the process of development(186,187). Each
of these systems has its own advantages and disadvantages.
As an example, the most widely used system for brain imaging
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and clinical applications to date has been the continuous-
wave system, which provides continuous, extended recording
with a high temporal resolution, is easy to apply, allows move-
ment during measurement and is comparatively cheap and
portable and of very low running costs. However, its major
disadvantages include its limited depth of penetration and its
use of an arbitrary value for the (unknown) path length of
light in its calculation of Hb concentrations (using a modified
Beer–Lambert formula), therefore only providing ‘change in
concentration’ measurements rather than quantifying the
absolute levels of oxy-Hb and deoxy-Hb(188). It is therefore
only suited to measuring the haemodynamic responses to
task-related neural activation or the acute and chronic effects
of an intervention in terms of how it modulates the haemo-
dynamic response to task performance. It is also ideal for
continuous measurement of the very short-term (maximum
of several hours) effects of acute interventions. Recent ‘quan-
titative’ systems resolve this measurement issue by collecting
light at several increasing distances from the light source,
allowing the exact calculation of the path length and thereby
the absolute quantity of Hb in the underlying tissue. These
systems, which have advantages in terms of cost and practical
considerations similar to those of earlier continuous-wave sys-
tems, will be ideally suited to studies of either the acute or
chronic effects of an intervention in terms of both absolute
quantities and haemodynamic responses. While NIRS par-
ameters have been shown to correspond strongly with the
fMRI BOLD signal(174,189,190), there are advantages and disad-
vantages associated with the two imaging techniques. NIRS
has a high temporal resolution (up to 250 Hz) and is certainly
comparatively cheap, easy to use and suitable for measuring
during most tasks for long periods. It also generates data
that can be analysed using standard statistical methods.
However, it does not have the comparatively high spatial
resolution of fMRI, and it only provides information about
blood flow parameters in the upper layers of the cortex.
Eligibility for a near-IR spectroscopy examination
NIRS originated as a clinical tool(191) and continues to be
widely used across the lifespan in this context. For example,
its uses include the monitoring of cerebral haemodynamics
and oxygenation across critical illnesses in neonates, infants
and children(192). It is also used during anaesthesia(193) and
in clinical research into neurological conditions, including
perinatal asphyxia, epilepsy and brain development(194,195).
Similar applications in adults include use during surgery,
resuscitation and cardiac failure(196,197) and the identification
and rehabilitation of brain injury(176,196,198). NIRS has also
been used to demonstrate reduced CBF or haemodynamic
responses during cognitive tasks in groups suffering from a
number of neurological or neurodevelopmental conditions,
including age-associated cognitive impairment and demen-
tia(199), schizophrenia(200) and attention-deficit hyperactivity
disorder (ADHD)(201).
NIRS has also proven itself to be a sensitive research tech-
nique for assessing the modulation of CBF across the lifespan,
from neonates(175) to older adults(177,181), in diseased and
healthy subjects, and it reliably illuminates age-related
changes in CBF elicited by sensory stimuli or cognitive task
performance(179,180,182–184). In general, NIRS research has
been conducted in mixed-sex groups.
NIRS has rarely been employed in pharmacological trials in
adult samples. Beyond a number of drug trials related to its
clinical use in anaesthesia(202), it has been used to demon-
strate a reduced haemodynamic response in the prefrontal
cortex during cognitive tasks following methylphenidate use
in children with ADHD(203) and following sedating antihista-
mine use in children(204). Similarly, it has been used to
show decreased frontal lobe oxygenation following the
administration of sumatriptan(205) and phenylephrine(206)
and increased oxygenation following the use of the vasodila-
tor vinpocetine(207).
Use of near-IR spectroscopy in nutritional studies
NIRS provides an accessible measure of the CBF effects of the
many nutritional factors and dietary components that may
modulate blood flow either over the short term or indeed
across the lifespan. However, to date, only a handful of studies
have utilised NIRS to assess the cerebral haemodynamic
effects of nutrients and food components. The only such
study in infants(208) has demonstrated reduced CBF (tissue
oxygenation index representing the ratio of oxy-Hb:deoxy-
Hb) in the temporo-parietal region following the adminis-
tration of a single dose of caffeine, administered primarily as
a respiratory stimulant, to forty preterm infants. A number of
double-blind, placebo-controlled trials have also assessed
the effects of nutritional interventions on CBF/neural activity
in adults as measured by one or two channels positioned
over the frontal cortex during tasks that activate this brain
region. For instance, Kennedy & Haskell(209) confirmed the
vasoconstricting properties of caffeine in healthy adults (total
Hb, n 20, cross-over design). NIRS has also been used to
demonstrate a dose-related increase in CBF (total Hb) and
deoxy-Hb level in the frontal cortex during task performance
following the administration of single doses of the polyphenol
resveratrol (n 22, cross-over design(210)) and a decrease in CBF
(total Hb) during tasks following the administration of two
single doses of the tea polyphenol epigallocatechin gallate
(n 27, cross-over design(211)). The above-mentioned findings
mirror those from studies using a variety of other imaging
techniques in the case of caffeine and animal models in the
case of the polyphenols. Several controlled trials have also
investigated longer intervention periods. For instance, Wata-
nabe et al.(212) demonstrated modulated haemodynamic
responses in terms of decreased oxy-Hb and increased
deoxy-Hb levels during cognitive tasks following 5 d adminis-
tration of creatine to a small sample of adults (n 24, parallel
groups). In two investigations of the effects of n-3 fatty
acids, Jackson et al.(213) demonstrated that 12-week adminis-
tration of DHA-rich fish oil, but not of EPA-rich fish oil,
increased the frontal cortex haemodynamic response in
terms of total Hb and oxy-Hb during ‘frontal’ task performance
in a small sample of twenty-two healthy young adults. Jackson
et al.(214) subsequently confirmed the dose-dependent nature
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of the effects of the DHA-rich fish oil in a larger sample of
sixty-five adults.
Methodological limitations and recommendations of
relevance to intervention studies
Taken together, these studies suggest that NIRS is adequately
sensitive to detect the CBF effects of nutrients and food com-
ponents. However, although NIRS can be used to reliably
demonstrate CBF and haemodynamic responses to cognitive
task performance, there is little evidence to date of a direct
relationship between changes in CBF inculcated by nutritional
interventions and corresponding benefits in terms of the
speed or accuracy of cognitive performance per se. This col-
lection of studies also highlights the constraints associated
with much of the NIRS research to date. The first of these is
that the studies have generally only employed either one or
two channels, typically covering the prefrontal cortex, rather
than the distributed network of channels across the frontal
cortex or head that the technique can accommodate. The
second is that the most commonly used continuous-wave
NIRS systems can only measure changes in concentrations
during the period of recording, rather than providing data
reflecting the absolute levels of oxy/deoxy-Hb. This makes
them well suited to assessing the acute effects of an interven-
tion, such as caffeine or resveratrol (with uninterrupted
recording from pre-dose), or suitable for assessing the effects
of a chronic treatment in terms of the magnitude of the
increase from a resting baseline in blood flow/volume
during task performance (i.e. the haemodynamic response).
The latter measure is undoubtedly of interest, but it alone is
unlikely to constitute the main outcome of any study assessing
the effects of long-term administration of nutrients or
indeed the cross-sectional/prospective relationships between
nutrients and brain function.
It is also necessary to note that the more recently introduced
quantitative NIRS systems combine the ease and mobility of
measurement, portability and low costs of the continuous-
wave systems and generate data representing the absolute
quantity of oxy/deoxy-Hb in the interrogated cortical tissue.
This step change in measurement technology, in concert
with increased sophistication in terms of the number and
location of channels across the head, should make NIRS a
particularly useful and cost-effective imaging technique in
nutrition-related studies in the future, especially as NIRS can
be combined successfully with most other imaging techniques
and can be used across ages and in concert with complex
cognitive or physical movement paradigms.
Positron emission tomography imaging: anatomical,
metabolic and functional assessments for nutritional
research
Positron emission tomography techniques and positron
emission tomography-derived measures
Functional neuroimaging procedures, such as PET and SPECT,
measure the metabolic and physiological processes of the
CNS. When combined with structural imaging techniques,
PET and SPECT determine the exact anatomical location and
the physiological and metabolic effects of a nutrient on the
brain.
To perform PET, a radiotracer is produced by attaching a
radioactive atom to a molecule or a compound of biological
interest. Directly following its synthesis, the radiotracer
begins to decay and release positively charged positrons from
the nucleus. A positron has the kinetic energy to travel a few
millimetres within the tissue. When almost at rest, the positron
interacts with an unbound electron. Since the two particles
have an opposite charge, they annihilate each other, resulting
in two g-ray photons of 511 keV energy being emitted at 1808
from each other(215). In a PET scanner, rings of radiation detec-
tors that surround an individual’s head for brain studies or
another body part of interest detect the g-ray photons. Pairs
of these radiation detectors are oriented to face each other at
1808 and are connected by an electronic coincidence circuit
that detects the photons emitted during the annihilation event
when the positron meets an electron and that converts light
energy into electrical energy to measure the number of
photon pairs originating from all angles in the brain. Through
a computer reconstruction algorithm, it is possible to determine
both the amount and location of the g-ray photons on a
regional basis throughout the brain and to produce a three-
dimensional image or picture. Due to the distance of few milli-
metres travelled by the positron before the annihilation event
occurs, PET has an intrinsic limitation in spatial resolution.
The number of positron/electron collisions at each site in the
brain is proportional to the amount of the radiotracer present
at the site. Hence, the relative amount of relevant activity
being evaluated with respect to activity at other brain sites
can be determined.
PET enables in vivo visualisation by tracking radioactive
compounds (i.e. radiotracers) that are of potential biological
importance in the body(216). PET tracers typically are identical
or similar in structure (i.e. they are analogues) to naturally
occurring molecules that act in particular brain areas. Depend-
ing on the radiotracer, PET can provide measures of regional
cerebral glucose metabolism, blood flow and neurotransmitter
metabolism in a variety of physiological conditions and in
neurological or psychiatric disorders(217).
The best-known example of a PET tracer is [18F]fluoro-
2-deoxy-D-glucose (FDG). FDG is an analogue of glucose
that is labelled with 18F and has a radioactive half-life of
110 min. Glucose serves as the source of energy in active
brain cells. Thus, regional cerebral metabolic rates for glucose,
as determined using PET with this tracer, represent a reliable
index of functional synaptic activity in the human
CNS(218,219). After an intravenous bolus injection, FDG reaches
the brain via blood flow and, similar to glucose, can be trans-
ported across the cerebral capillary bed into the neurons by a
monosaccharide transport system. Once inside brain cells,
FDG is phosphorylated to FDG-6-phosphate, but unlike
glucose-6-P, FDG-6-phosphate is not further metabolised by
glycolytic pathway enzymes and remains essentially trapped
inside brain cells during the duration of the scan(219). There-
fore, the quantity of FDG-6-phosphate that has accumulated
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in a brain region during 45 min of uptake after FDG intrave-
nous injection is measured by PET, and it reflects the rate of
phosphorylation of glucose to glucose-6-P and the plasma
integral of FDG to which the brain is exposed(220). Using an
operational equation(219), regional cerebral metabolic rates
for glucose are calculated from the quantity of FDG-6-phos-
phate within the brain, the ratio of the integrated plasma
activity of FDG to non-radiolabelled plasma glucose concen-
tration during 45 min of uptake and a ‘lumped constant’ that
corrects for the use of FDG in place of unlabelled glucose.
By binding the radioactive compound to specific proteins
(e.g. transporters, receptors or enzymes), PET can be used
to evaluate the state of neurotransmitter systems, revealing,
for instance, the activity of enzymes involved in the synthesis
and metabolism of a given neurotransmitter, such as serotonin
or dopamine, or the number of receptors present(221). PET
may also reveal the variety of physiological processes
mediated by the receptor system. In general, the dose of the
radiotracer for a routine PET scan is approximately 1000
times lower than that required to produce a pharmacological
effect(222). Hence, the radiotracer does not interfere with the
ongoing conditions under study.
In addition to fluorine, other radioactive atoms used in PET
studies are carbon (11C) and oxygen (15O). As a freely diffusi-
ble tracer, H2
15O quickly equilibrates between brain and
blood and provides an excellent indicator of regional CBF
(rCBF), another reliable index of neuronal activity. Immedi-
ately following an intravenous injection of a bolus of H2
15O,
a PET scan that can last from 1 to 4 min is acquired to measure
local radioactivity in the distinct cortical and subcortical brain
regions. Radioactivity can be concurrently measured in the
blood by sampling from an indwelling arterial line that is con-
nected to an automatic counter. Using a mathematical model,
it is possible to determine absolute rCBF values in terms of
ml/100 g tissue per min.
Since the radioactivity of 15O has a rapid decay (half-life
2·05 min), multiple scans can be performed sequentially in
the same individual, ranging from 6 to 12 min apart. This
makes it possible to evaluate rCBF repeatedly in a single
PET session, while the subject is in the ‘resting state’ with no
sensory stimulation or engaged in performing a variety of
tasks. By subtracting a baseline rCBF scan from a task rCBF
scan, regions where activity is specifically altered during the
task can be identified. In such rCBF studies, arterial blood
PaCO2 is monitored so that global CBF can be corrected
when differences in PaCO2 occur. Over the last few years,
fMRI has largely been replaced with PET to study changes in
regional brain activity by measuring blood flow-related
phenomena, because of the greater space and time resolution
and the lack of any radioactive exposure.
Due to its methodological features and radionuclide speci-
ficities, PET is adapted to measure neural activations during
specific tasks and the acute and chronic effects of an inter-
vention in terms of how it modulates both the neural res-
ponse to task performance and the metabolism of different
neurotransmitters.
Eligibility for an examination with positron emission
tomography
PET scanning is useful for understanding adult brain function,
but the use of short-life radioactive compounds poses a strict
limitation to the number of PET scan examinations that an
individual may undergo within a given period of time. It is
also considered impractical to use this approach in healthy
children and adolescents for radiation safety reasons. Hence,
in the young, the technology is only used for diagnosis in
which the risk is outweighed by the benefit.
Use of positron emission tomography in nutritional studies
The number of nutritional studies using PET techniques is
limited. This is not surprising due to the high cost of the
technology, its limited availability and the short half-life of
radiotracers. Due to radiation, most of the studies available
either have examined the effect of nutrition in the adult
brain or are clinical studies in children. Past studies have lever-
aged PET analysis as a tool for identifying the effects of
various stimuli on neurotransmission, blood flow and glucose
uptake. The technique can map potential CNS mechanisms
mediating whole-body energy balance by regulating energy
intake and expenditure in healthy men and women and in
those deviating from ‘healthy’. These data show that inter-
individual and sex differences in behaviour may have
neurobiological correlates. In several studies(172,223–225), PET
has been used to measure rCBF, a marker of neuronal–synap-
tic activity, to investigate the functional neuroanatomy of sex
differences and differences between lean and obese individ-
uals in hunger and satiation. Hunger was associated with
significantly increased neuronal activity in the vicinity of the
hypothalamus and thalamus, which are areas described
previously as important in the regulation of feeding behaviour
in animals. Hunger was also associated with increased
activation in the vicinity of the limbic and paralimbic areas,
regions involved in affect and motivation. In contrast, satiation
was associated with increased activity in prefrontal cortical
areas implicated in aspects of response inhibition. The
changes in activity in the putamen and cerebellum associated
with hunger suggested the involvement of brain regions not
previously associated with the regulation of food intake. PET
has also demonstrated extensive similarities, as well as some
differences, between the sexes. In response to hunger, men
tended to have greater activity in the frontotemporal and para-
limbic systems than did women(172). In response to satiation,
women tended to have greater activity in the occipital and
parietal sensory association areas and in the dorsolateral pre-
frontal cortex than did men, and men tended to have greater
activation in the prefrontal cortex than did women(172). Sex-
specific responses indicate possible neurobiologically based
differences in men and women in cognitive and emotional
processing of hunger and satiation.
Only a few neuroimaging studies have explored the effects
of modifications in nutritional lifestyle on the brain functional
and anatomical correlates. Small et al.(226) have recently used
PET with cognitive and memory tests to assess brain metabolic
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and functional correlates of a 14 d healthy longevity pro-
gramme. Volunteers in the intervention programme were
requested to follow a diet plan and to practise relaxation exer-
cises, cardiovascular conditioning and mental exercise (brain
teasers and verbal memory training). The diet plan used in
this study included five daily meals and emphasised antioxi-
dant-rich fruits and vegetables, n-3 fats and low-glycaemic
index carbohydrates. FDG-PET scans and cognitive tests
were performed before and after the intervention, and the
results were compared with those obtained from a group of
control subjects, who continued with their usual lifestyle rou-
tine. Individuals in the intervention group showed improved
performance in a word fluency test, while the PET scans ident-
ified a 5 % decrease in cerebral glucose metabolism in the
dorsolateral prefrontal cortex. The authors interpreted these
results as signs of increased cognitive efficiency consequent
to the temporary modification in lifestyle.
Another neuroimaging study has investigated brain func-
tional correlates of dietary restraints and successful dieting.
Del Parigi et al.(227) used an H2
15O radiotracer to evaluate
brain response to the sensory experience of food consump-
tion comparing a group of successful female dieters (i.e. suc-
cessful weight loss maintainers) with a group of non-dieters.
The authors observed that after meal consumption, successful
dieters showed greater brain activation in the dorsal prefrontal
cortex, dorsal striatum and anterior cerebellar lobes when
compared with non-dieters. Vice versa, the orbitofrontal
cortex showed greater activation in non-dieters when com-
pared with successful dieters. In addition, dietary restraint,
assessed using the Three-Factor Eating Questionnaire(228), cor-
related positively with the response in the dorsal prefrontal
cortex and negatively with the response in the orbitofrontal
cortex. Finally, a negative correlation was observed between
the response in the dorsal prefrontal cortex and that in the
orbitofrontal cortex. Given these results and the role
recognised for these two brain regions in cognitive control
of behaviour(229) and codification of the reward value of
stimuli(230), respectively, the authors hypothesised that an
inhibitory loop may exist between these two areas in success-
ful dieters. In other words, cognitive control of food intake
may be achieved, thanks to a modulatory signal generated
in the dorsal prefrontal cortex, and directed to regions
involved in food reward such as the orbitofrontal cortex(231).
Nugent et al.(232) questioned whether cerebral glucose
hypometabolism mediates changes in cognitive function
during healthy ageing. Based on epidemiological studies
suggesting that dietary n-3 PUFA ingestion from weekly con-
sumption of a fatty fishmeal protects cognitive function in
the elderly, the study sought to determine whether fish oil
supplementation rich in n-3 PUFA increases cerebral glucose
metabolism. PET analyses utilising [18F]FDG were used to
assess cerebral glucose metabolism in young and elderly
adults. Healthy young and elderly subjects received fish oil
capsules daily for 3 weeks (DHA and EPA). Both brain
18FDG-PET analysis and an oral glucose tolerance test were
performed at baseline and at the end of the treatment. The
results failed to differentiate age or n-3 PUFA supplementation
effects on glucose metabolism in any of the brain regions
evaluated.
Because of the limited number of existing reports, we
describe types of studies that could usefully employ PET ana-
lyses to examine the effects of a nutritional intervention on
brain function. Published study protocols for children with
Tourette’s syndrome or ADHD illustrate how PET imaging
can be used with regard to a nutritional intervention to modu-
late brain function. Tourette’s syndrome is a neurological
condition presenting with chronic motor and phonic tics
during childhood that persists into maturity. Current standard
treatment achieves partial control of the condition and pro-
vokes significant adverse effects. In 2002, Grimaldi(233)
hypothesised that Mg and vitamin B6 deficiencies may be
the precipitating factors in the neurochemical pathways med-
iating Tourette’s syndrome symptomatology. To confirm this
hypothesis, Garcia-Lopez et al.(234) reported on a study proto-
col designed to assess the effects of a combination of Mg and
vitamin B6 supplementation v. placebo on metabolic changes
measured by PET in the brain in conjunction with a reduction
in motor and phonic tics and incapacity, as well as in quality
of life, in children aged 7–14 years with exacerbated Tour-
ette’s syndrome(234). PET imaging will be performed before
and after the treatment, in order to ascertain treatment effects
on dopaminergic activity within the basal nuclei and in the
prefrontal cortex. Thus, PET imaging can be employed as a
tool to evaluate alternative hypotheses of nutritional effects
on brain function under clinical conditions.
PET has been used to examine brain metabolism in children
with ADHD(235). ADHD is a very common and heterogeneous
disorder with an onset in children. The key features include
persistent symptoms of inattention, hyperactivity and impul-
sive behaviour. Approximately 15 % of patients appear
refractory to the standard of care with psychostimulants. Dys-
function of the dopamine transporter is known to be involved
in its pathogenesis. Because the dopamine transporter is
regulated by Zn, Zn deficiency may contribute to the dysfunc-
tion of the dopamine receptor and its supplementation may be
required for treatment and/or as an adjunct to the psychosti-
mulants(236). Lepping & Huber(236) have proposed to test
their hypothesis by recruiting Zn-deficient ADHD patients
who will undergo PET with the [11C]raclopride displacement
method to investigate whether Zn increases extracellular
dopamine levels.
Later in life, PET could be used to study the effects on brain
functioning and metabolism of nutrients thought to be effica-
cious in maintaining, preventing or reversing cognitive decline
among the elderly. The ability to avert, or at least reduce, the
rate of cognitive decline in the elderly would be enormously
beneficial to public health. The most common form of cogni-
tive decline in the elderly is AD. The global presence of this
condition is expected to increase considerably over the next
few decades, resulting in overwhelming demands for socio-
economic and medical resources(237). Although various
forms of therapeutic interventions have been used in AD, no
treatment has proven capable of curing or remitting the
progression of the disease. The clinical demonstration of
potential treatments is arduous since it necessitates large
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study populations and long-term follow-up. PET analyses may
offer cost–benefit options to evaluate alternative therapies.
For example, emerging science has indicated that regional cer-
ebral glucose hypometabolism as measured by 18FDG-PET
reflects cognitive decline associated with ageing(238,239) and
dementia, such as AD(240). Hence, treatments that attempt to
reverse or retard the course of illness by enhancing glucose
utilisation of neurons, which can be assessed by PET with
the FDG radiotracer, may prove efficacious.
In the future, PET analyses may represent an important tool
in evaluating the effects of nutrient deficiencies and sup-
plementation on neurotransmission, glucose uptake and
blood flow underlying the pathological conditions.
Methodological limitations and recommendations of
relevance to intervention studies
Developing models for interpreting findings of positron emis-
sion tomography analyses. Most of the radiotracers used for
PET have relatively short half-lives. For example, the half-lives
for radiotracers of carbon and oxygen are 20 and 2 min,
respectively(222). As a result, PET radiotracers must typically
be produced at the same site as the PET scan activities in
order to avoid losing most of the radioactivity. Radiotracers
are produced by cyclotrons, machines that are extremely
expensive and bulky, and require radioactive shielding.
Hence, PET scans are also limited in availability. In contrast,
recent developments in radiotracers have provided products
with longer half-lives that permit the possibility of PET scan
usage in facilities without cyclotrons.
Data obtained with PET are typically subjected to a set of
processing steps to yield useful information. PET follows the
progress of the tracer by measuring the amounts of radioac-
tivity in different areas of the brain as well as the tracer
concentrations in the blood. These dual datasets are subjected
to mathematical or statistical modelling methods for
interpretation. For example, mathematical representations of
physiological processes such as the metabolism of neuro-
transmitters are used to develop mathematical equations
describing the tissue response curve expected in the measure-
ments. The tissue response curve plots the radioactivity of
specific parts of the brain before, during and after the radiotra-
cer injections. By identifying those variables in the model that
give the best agreement between the expected and measured
values, the physiological processes can be quantified.
Correcting for partial volume errors. Compared with struc-
tural imaging (e.g. MRI), PET images are blurred due to the
limited resolution of the scanners (i.e. inability to distinguish
between closely spaced regions of small dimensions). This
may result in two consequences: (1) an apparent loss or
spill-out of radioactivity signals from a small region of interest
into the adjacent tissues due to the size of the small brain
region compared with the spatial resolution of the scanner,
or (2) spill-in of radioactive signals into the regions of interest
from adjacent brain areas with different radioactivity tracer
concentrations. The latter are known as partial volume
errors. Corrections for partial volume errors involve computer
simulations to mimic the effect of limited spatial resolution in
order to characterise the partial volume effects for each
brain region. This information allows the application of cor-
rection factors to obtain more accurate estimates of the
actual regional activity.
PET scans are increasingly read alongside a computed tom-
ography or MRI scan. The combination gives anatomical and
metabolic information (what the structure is and what it is
doing biochemically). However, the MRI–PET procedure is
time consuming, technically demanding and expensive.
Hence, it is not widely available and is used in limited research
settings.
Single-photon emission computerised tomography
imaging: anatomical, metabolic and functional
assessments for nutritional research
Single-photon emission computerised tomography
techniques and single-photon emission computerised
tomography-derived measures
Similarly to PET, SPECT is a tomographic imaging method-
ology that employs g-ray-emitting radioisotopes that are
attached to ligands of interest. In SPECT imaging, however,
isotopes that emit a single g-ray photon are used. This funda-
mental difference from the radiotracers used in PET, which
emit two photons, accounts for the principal differences in
instrumentation and capabilities to measure functional brain
activity. SPECT visualises the physiological or metabolic func-
tioning of living human subjects, and it is mainly used to
measure blood perfusion and neurotransmitter distribution
in a variety of physiological conditions and in neuropsychia-
tric disorders.
The principal radiotracers currently used in SPECT assess
neural activity by measuring rCBF, although radiotracers to
assess the characteristics of several neuroreceptor systems,
including the cholinergic, dopaminergic and serotoninergic
systems, have also been developed(241,242). The most com-
monly used radiotracers to measure rCBF in SPECT include
[99mTc]hexamethylpropyleneamine and [99mTc]ethyl cysteinate
dimer. The radiotracer [123I]isopropyl iodoamphetamine has
also been widely used to measure rCBF with SPECT. Although
employed initially in non-tomographic imaging, the use of
Xe-133 has continued with SPECT. With a relatively fast clear-
ance, this particular radiotracer allows for multiple scans in the
same SPECT session, but offers a relatively low spatial resol-
ution(243). With the implementation of multiple-head SPECT
cameras, sensitivity and spatial resolution have significantly
improved. However, SPECT continues to have a lower spatial
resolution than PET and has a greater difficulty in identifying
deep brain structures.
In general, compared with positron-emitting tracers in PET,
the radioisotopes in SPECT emit lower-energy photons (i.e.
80–159 keV). These are more susceptible to attenuation as
the photons travel through tissue, especially in deeper brain
structures. Thus, brain structures similar to the basal ganglia,
which are farther from the detector surface, have a poorer res-
olution than cortical brain regions. This, in combination with
the complexities in modelling tracer behaviour, makes full
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regional quantification of absolute rCBF difficult in SPECT. In
practice, which is also often the case with PET, regional tissue
counts in the cortex are typically referenced to global tissue
counts or relatively preserved brain regions (e.g. cerebellum)
to provide a semi-quantitative measure of cerebral perfusion.
As with PET, SPECT imaging of the brain involves two
essential steps: (1) the administration of a radiotracer and
(2) the use of a tomographic scanner to measure the regional
distribution of the radiotracer in the brain. In SPECT, as in PET,
scintillation crystals are used to detect the radioactivity emitted
from the tracers. Since the emitted photons travel in all direc-
tions, SPECT depends on the use of collimators to determine
the point of origin of the emitted photons and to localise
the regional brain activity. These collimators are in the form
of lead septa that are positioned in front of the scintillation
crystal detectors. The apertures created between the septa
serve to limit the exposure of the crystals to g-ray photons
that are arriving at a nearly perpendicular angle to the crystal
surface. In PET, such septa are employed for two-dimensional
image acquisition, but can be retracted in the new three-
dimensional image scanners.
Furthermore, the radioactive half-lives of 6 h for 99mTc and
13 h for 123I, as well as the relatively slow washout of the
high-resolution tracers, such as [99mTc]hexamethylpropylenea-
mine and [123I]isopropyl iodoamphetamine, significantly limit
the ability to perform multiple scans to assess rCBF under
different test conditions during the same scanning session.
Importantly, the greater ease of production and the poten-
tial for longer storage of these radiotracers, compared with
the positron-emitting radiotracers used in PET, provide the
advantage of eliminating the need for an on-site cyclotron.
Despite the technical limitations of SPECT relative to PET,
the wide availability and lower cost, combined with the ability
to detect regional reductions in cortical perfusion with a
spatial resolution that can approach that of PET, have made
its use more popular in clinical assessments of neurodegenera-
tive diseases in recent years. For detailed reviews of the pro-
cedures and technical considerations for SPECT, see the
works of Devous et al.(244), Juni et al.(245), Masdeu et al.(246)
and Van Heertum & Tikofsky(247).
Eligibility for a single-photon emission computerised
tomography examination
SPECT scanning is mostly used for clinical purposes only,
mainly in adult patients. It is considered impractical to use
this approach in healthy children and adolescents primarily
for reasons of radiation safety.
Use of single-photon emission computerised tomography
in nutritional studies
SPECT shares clinical and research applications, limitations
and methodological aspects with PET. Indeed, SPECT scan-
ning has been mainly exploited for the possibility of assessing
cerebral perfusion changes related to nutritional abnormal-
ities. For instance, [99mTc]ethyl cysteinate dimer brain SPECT
studies have revealed significant decreases in frontal perfusion
in a group of patients with coeliac disease, similarly to what
has been described previously in other autoimmune diseases
but improvable by a gluten-free diet(248). Similarly to what
has been described previously, SPECT has also been used
for evaluating changes in neurotransmitter metabolism in
patients with eating disorders or obesity(249,250) or to deter-
mine the effects of creatine nutritional supplementation in
Parkinson’s disease(251) or vitamin B12 deficiency
(251,252) on
brain functioning.
Methodological limitations and recommendations of
relevance to intervention studies
The limitations and consideration relative to the methodologi-
cal, experimental and data processing aspects that have been
highlighted for PET are also valid for SPECT. As for PET
protocols, but often with a lower spatial resolution and an
ill-defined quantification of the activity distribution, SPECT
use faces the issues of specificity and the intrinsic properties
of radiotracers, the limited availability of scanners and the
elaborate processing of images.
General considerations
The present review describes existing brain imaging technol-
ogies and how these have the potential to assess the effects
of a nutritional intervention in human subjects. From early
development to ageing, brain imaging can detect structural,
functional and metabolic changes in human subjects. In
addition, modifications due to altered nutrition or to additional
nutritional supplementation have recently been evaluated
with some of these techniques. There are two things that
seem clear: first, the use of brain imaging in nutritional studies
is not widespread; second, brain imaging techniques offer the
promise of providing important and useful information about
the effects that nutrition has on brain metabolism, structure
and function. The literature reviewed here suggests that, on
the whole, the brain imaging markers described can reliably
reflect neurostructural, neurophysiological, neurochemical
and functional cerebral changes occurring during the lifespan
and potentially after nutritional interventions. Furthermore,
these markers may increase our understanding of changes in
brain and cognitive function associated with nutritional inter-
ventions(66,67,69,76,84,94,137,145,209,211–213,231,232,248,251,252). Signi-
ficant effects of a short-term intervention with foods and
nutrients have been demonstrated using MRI, EEG, NIRS and
PET in adults, including sex effects, and special populations
such as athletes(156,172,223–226). Moreover, significant effects
of a long-term intervention (i.e. months) with foods and nutri-
ents have been demonstrated by these techniques in infants
and children, as well as in elderly subjects(3,12,153–166). Due
to the relative infancy of most of these technologies, for the
vast majority of imaging measures, little information is avail-
able regarding their correlation with functional endpoints in
healthy subjects. Therefore, in the general healthy population,
the use of imaging markers as surrogates for functional
endpoints is not well developed and for most markers it is
inappropriate. The key added value of these measures for
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human nutritional intervention studies is their opportunity to
provide unique in vivo information on the working mechan-
ism of the intervention.
Although imaging techniques are capable of providing new
and reliable information on brain structure and function, it
must be remembered that they have their limitations and cau-
tion must be exercised, particularly when interpreting negative
results. Finding no imaging changes may indicate that the
intervention has had no effect on brain structure and/or func-
tion. An equally valid conclusion, however, may be that the
imaging methodology is not sensitive enough to reveal
changes that have in fact occurred. In addition, while beha-
vioural measures of cognitive function in longitudinal studies
are often subject to, for instance, relatively large practice
effects that may complicate the interpretation of results,
many imaging measures are not. Finally, functional brain ima-
ging techniques provide parametric continuous variables with
a high resolution of values, whereas behavioural tests provide
only non-parametric ranking variables that might be incapable
of discriminating slight effects of the intervention. However,
the computerised psychophysical tests of attention, memory,
etc. provide continuous variables of cognitive performance
(reaction time, response time and accuracy). It should also
be stressed that these studies tend to show a large inter-
individual and inter-group variance and that the brain imaging
markers are acceptable for use at a group level but not yet at
an individual level. This conclusion suggests the need for
further investment to develop more precise and effective
guidelines for the standardisation, harmonisation and
qualification of data collection and its analysis in nutritional
intervention studies. This may shorten the time for obtaining
final conclusions about the effects of the intervention.
Hypothesis tested regarding the mechanism of action
of the intervention
Becauseof the limitednumberofexisting reports,wedescribe the
types of studies that could usefully employ the imaging methods
described above to examine the effects of a nutritional interven-
tion on the brain. The choice for most appropriate measures
depends on the hypothesis regarding the mode of action of a
nutritional intervention on brain function (i.e. on which neuro-
structural, neurophysiological and neurochemical changes are
expected due to the intervention). Combination of various
imaging measures of different phenomena of the hypothesised
working mechanism can provide complementary information
and strengthen hypothesis testing. For example, de Wilde
et al.(253) reviewed the potential of imaging modalities to test
the hypothesis that a nutritional intervention increased the
formation of new neuronal membranes and therewith synapse
formation and function in AD. To test this specific hypothesis,
MRS can be employed to study membrane-related compounds,
cerebral metabolic rate of glucose by FDG-PET can provide
insights into synaptic functioning and density, and structural
MRI can be used to study long-term effects on atrophy rate,
while EEG and MEG might be useful to study functional
connectivity.
Level (structural, metabolic or functional) and anticipated
timescale of the intervention’s effects
In this regard, the intrinsic temporal and spatial resolution of the
different brain imaging techniques will determine the choice
of technique. For example, structural MRI would not be
appropriate in an acute intervention context (i.e. single-dose
administration or few days of administration). However, these
techniques could be included in the general assessment of the
experimental subjects if the experimental purposes imply the
exclusion of elderly people with preclinical neuropathological
processes as indexed by abnormal cortical grey matter, white
substance, hippocampus volume, vascular load and so forth.
Furthermore, validation of a nutritional intervention in terms
of structural MRI effects may yield especially strong evidence
in favour of a nutrient, as structural effects may be expected
to have long-term consequences on CNS function.
Target population and ethical restrictions
Most of these imaging techniques are non-invasive and are ethi-
cally suitable for use in almost any population throughout the
lifespan. However, some can be limited in their use, and this
should be addressedduring studydesign to seek alternative ima-
ging markers. For example, PET techniques can be extremely
useful in examining the effects of nutritional interventions on
brain metabolism and CBF in human subjects. However, there
are ethical restrictions for their use in healthy subjects and
these techniques are not suitable for infants and children.
Availability and costs of the techniques
Some promising procedures might not be viable due to the lack
of current availability (i.e. MEG, NIRS or PET) or relatively high
costs of their use (i.e. PET and MRI). These aspects may be
relevant in the case in which the study plan implies the recruit-
ment of a large number of control and experimental subjects.
Conclusion
In the present review, we have provided a comprehensive
overview of brain imaging markers that have potential utility
in nutritional intervention studies examining CNS and cogni-
tive function in healthy human subjects. We have described
multimodal MRI, as well as EEG/MEG, NIRS, PET and SPECT
techniques, with a focus on the biological relevance of their
outcome measures, the practical use and feasibility of the tech-
niques, and the recommended use in terms of acute v. chronic
nutritional intervention studies. In general, brain imaging mar-
kers for nutritional intervention studies can be considered as
specific for one or several brain processes and as surrogate
instrumental endpoints. They are also suitable to build up
translational models to be used in both animals and human
subjects to validate preclinical research. However, these mar-
kers cannot be considered as a substitute of clinical endpoints
in terms of cognitive or behavioural response to a task or chal-
lenge. Furthermore, some brain imaging markers can be
linked to a broader functional outcome, such as cognition,
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behaviour or wake–sleep cycle, but they certainly do not
replace the overall capacity of the brain to behaviourally
respond to a specific situation and stimuli that should
remain the essential endpoints. The best way to evaluate the
effects of food and nutrients on the CNS is to use a proper
panel of structural and functional brain imaging markers and
of behavioural, psychophysical and clinical (if any) endpoints,
in line with the specific working hypotheses on the neural
mechanism of action of the intervention. In this framework,
the correlation between brain imaging markers and beha-
vioural/psychophysical measurements represents an import-
ant aspect of the data analysis design to probe the sensitivity
of these neuroimaging markers to the effects of the interven-
tion at an individual level. An ideal view is that international
consensus guidelines will be developed in the near future
for the use of the appropriate brain imaging techniques for
nutritional intervention studies in healthy human subjects.
This would be a very promising platform for increasing the
use of these markers in future nutritional intervention studies.
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